Related Experiment Video

Updated: Jun 8, 2025

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

10.7K

Mucus-Penetrable Biomimetic Nanoantibiotics for Pathogen-Induced Pneumonia Treatment

Yue Wang1,2, Qihang Ding3, Gongcheng Ma2

  • 1Cancer Center, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China.

ACS Nano
|November 1, 2024
PubMed

Insights

New biomimetic nanoantibiotics overcome lung mucus barriers to precisely target bacterial pneumonia. These traceable nanoplatforms, coated with natural killer (NK) cell membranes, enhance antibiotic delivery and efficacy for improved infectious disease treatment.

Area of Science:

  • Infectious Diseases
  • Nanomedicine
  • Biomaterials

Background:

  • Bacterial pneumonia presents challenges due to increasing severe infections and limited effective treatments.
  • The mucus layer in the lungs hinders conventional antibiotic delivery and efficacy.
  • Developing advanced drug delivery systems is crucial for overcoming these therapeutic obstacles.

Purpose of the Study:

  • To develop traceable biomimetic nanoantibiotics (BioNanoCFPs) for enhanced bacterial pneumonia treatment.
  • To engineer nanoplatforms capable of penetrating lung mucus and targeting infection sites.
  • To leverage natural killer (NK) cell membranes for precise bacterial recognition and drug delivery.

Main Methods:

  • Loading indacenodithieno[3,2-b]thiophene (ITIC) and cefoperazone (CFP) into nanoplatforms.
  • Coating nanoplatforms with natural killer (NK) cell membranes to create BioNanoCFPs.
  • Evaluating mucus-penetrating abilities and bacterial targeting capabilities of BioNanoCFPs.

Main Results:

  • BioNanoCFPs demonstrated excellent mucus-penetrating properties, reaching infection sites effectively.
  • NK cell membranes facilitated recognition of pathogen-associated molecular patterns, enabling precise bacterial targeting.
  • The developed nanoantibiotics achieved substantial therapeutic efficacy against bacterial pneumonia.

Conclusions:

  • Biomimetic nanoantibiotics coated with NK cell membranes show promise for overcoming mucus barriers in bacterial pneumonia treatment.
  • NK cell membrane-mediated drug delivery offers a viable strategy for precision targeting and enhanced therapeutic outcomes.
  • This approach represents a significant advancement in nanomedicine for infectious disease management.
Keywords:
antibacterial treatmentsbacterial pneumoniabiomimeticmucus layernatural killer cells

More Related Videos

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

9.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
300
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
936